Elena Martin-Rodriguez1, Francisco Guillen-Grima2, Amelia Martí3, Antonio Brugos-Larumbe4. 1. Departament of Health Science, Public University of Navarra, Pamplona, Spain; Servicio Navarro de Salud, Spain. Electronic address: elenamartinr@gmail.com. 2. Departament of Health Science, Public University of Navarra, Pamplona, Spain; Departament of Preventive Medicine, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain; IdiSNA (Navarra Institute for Health Research), Spain. 3. IdiSNA (Navarra Institute for Health Research), Spain; Departament of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain; Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn), Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos III, Madrid, Spain. 4. Departament of Health Science, Public University of Navarra, Pamplona, Spain; Servicio Navarro de Salud, Spain; IdiSNA (Navarra Institute for Health Research), Spain.
Abstract
BACKGROUND: Overweight and obesity are major causes of comorbidities which can lead to further morbidity and mortality. The main objective of the present study was to estimate the comorbidity associated with obesity in 40,010 patients attending Primary Health Care Centres in Navarra. METHODS: It is a descriptive cross-sectional study. The association of overweight and obesity in different diseases was studied. Odds ratios (OR) adjusted for age and sex were calculated by unconditional logistic regression, using as reference patients with body mass index (BMI) lower than 25 kg/m(2). RESULTS: Increasing BMI is associated with glucose intolerance (OR: 1.07; 95% CI: 1.06-1.08), dyslipidemia (OR: 1.04; 95% CI: 1.03-1.04), hypertension (OR: 1.12; 95% CI: 1.12-1.13), type 2 diabetes (OR: 1.11; 95% CI: 1.10-1.11), kidney failure (OR: 1.04; 95% CI: 1.03-1.05), and osteoarthritis (OR: 1.06; 95% CI: 1.05-1.06). Moreover, all the degrees of obesity are associated with asthma (OR type I obesity: 1.33; OR type II obesity: 1.69; OR type III obesity: 1.75), heart failure (OR type I obesity: 1.68; OR type II obesity: 2.78; OR type III obesity: 4.35), and severe mental disorders (OR type I obesity: 2.02; OR type II obesity: 2.33; OR type III obesity: 2.50). Type II and morbid obesity are associated with chronic obstructive pulmonary disease and depression. CONCLUSION: Our study showed a positive association of the overweight and obesity with glucose intolerance, dyslipidemia, type 2 diabetes, hypertension, osteoarthritis, and kidney failure. An interesting point is the association of higher levels of BMI with depression.
BACKGROUND: Overweight and obesity are major causes of comorbidities which can lead to further morbidity and mortality. The main objective of the present study was to estimate the comorbidity associated with obesity in 40,010 patients attending Primary Health Care Centres in Navarra. METHODS: It is a descriptive cross-sectional study. The association of overweight and obesity in different diseases was studied. Odds ratios (OR) adjusted for age and sex were calculated by unconditional logistic regression, using as reference patients with body mass index (BMI) lower than 25 kg/m(2). RESULTS: Increasing BMI is associated with glucose intolerance (OR: 1.07; 95% CI: 1.06-1.08), dyslipidemia (OR: 1.04; 95% CI: 1.03-1.04), hypertension (OR: 1.12; 95% CI: 1.12-1.13), type 2 diabetes (OR: 1.11; 95% CI: 1.10-1.11), kidney failure (OR: 1.04; 95% CI: 1.03-1.05), and osteoarthritis (OR: 1.06; 95% CI: 1.05-1.06). Moreover, all the degrees of obesity are associated with asthma (OR type I obesity: 1.33; OR type II obesity: 1.69; OR type III obesity: 1.75), heart failure (OR type I obesity: 1.68; OR type II obesity: 2.78; OR type III obesity: 4.35), and severe mental disorders (OR type I obesity: 2.02; OR type II obesity: 2.33; OR type III obesity: 2.50). Type II and morbid obesity are associated with chronic obstructive pulmonary disease and depression. CONCLUSION: Our study showed a positive association of the overweight and obesity with glucose intolerance, dyslipidemia, type 2 diabetes, hypertension, osteoarthritis, and kidney failure. An interesting point is the association of higher levels of BMI with depression.
Authors: Stefany D Primeaux; Taniya de Silva; Tony H Tzeng; Monica C Chiang; Daniel S Hsia Journal: Rev Endocr Metab Disord Date: 2016-06 Impact factor: 6.514
Authors: Elisa J de Koning; Erik J Timmermans; Natasja M van Schoor; Brendon Stubbs; Tessa N van den Kommer; Elaine M Dennison; Federica Limongi; Maria Victoria Castell; Mark H Edwards; Rocio Queipo; Cyrus Cooper; Paola Siviero; Suzan van der Pas; Nancy L Pedersen; Mercedes Sánchez-Martínez; Dorly J H Deeg; Michael D Denkinger Journal: J Pain Date: 2018-03-02 Impact factor: 5.820
Authors: Young Kim; Alex L Chang; Koffi Wima; Audrey E Ertel; Tayyab S Diwan; Daniel E Abbott; Shimul A Shah Journal: Surgery Date: 2016-08-26 Impact factor: 3.982